Patients on HAART Often Have an Excess of Unintegrated HIV DNA: Implications for Monitoring Reservoirs

Overview

Journal Virology

Specialty Microbiology

Date 2010 Oct 26

PMID 20970154

Citations 22

Authors

Luis M Agosto

Megan K Liszewski

Angela Mexas

Erin Graf

Matthew Pace

Jianqing J Yu

Avinash Bhandoola

Una ODoherty

Affiliations

Soon will be listed here.

Abstract

HIV establishes a latent reservoir early in infection that is resistant to anti-retroviral therapy and has a slow rate of decay. It is thought that the majority of HIV DNA in treated patients is integrated since unintegrated HIV DNA appears to be unstable. Thus, to monitor the HIV latent reservoir, total HIV DNA is commonly measured in PBMC from infected individuals. We investigated how often total approaches integrated HIV DNA in treated patients. To do this, we first assessed how accurate our integration assay is and determined the error in our measurements of total and integrated HIV DNA. We demonstrated an excess of total over integrated HIV DNA was present in a subset of patients, suggesting that measurements of total HIV DNA do not always correlate to the level of integration. Determining the cause of this excess and its frequency may have important implications for understanding HIV latent reservoir maintenance.

Citing Articles

Primary HIV infection features colonic damage and neutrophil inflammation yet containment of microbial translocation.

Tincati C, Bono V, Cannizzo E, Tosi D, Savi F, Falcinella C AIDS. 2023; 38(5):623-632.

PMID: 38016163 PMC: 10942218. DOI: 10.1097/QAD.0000000000003799.

Quantification of Total HIV DNA as a Marker to Measure Viral Reservoir: Methods and Potential Implications for Clinical Practice.

Belmonti S, Di Giambenedetto S, Lombardi F Diagnostics (Basel). 2022; 12(1).

PMID: 35054206 PMC: 8774405. DOI: 10.3390/diagnostics12010039.

Ex Vivo Differentiation of Resting CD4+ T Lymphocytes Enhances Detection of Replication Competent HIV-1 in Viral Outgrowth Assays.

Wonderlich E, Reece M, Kulpa D Methods Mol Biol. 2022; 2407:315-331.

PMID: 34985673 DOI: 10.1007/978-1-0716-1871-4_21.

A comparative analysis of unintegrated HIV-1 DNA measurement as a potential biomarker of the cellular reservoir in the blood of patients controlling and non-controlling viral replication.

Orlandi C, Canovari B, Bozzano F, Marras F, Pasquini Z, Barchiesi F J Transl Med. 2020; 18(1):204.

PMID: 32429953 PMC: 7236182. DOI: 10.1186/s12967-020-02368-y.

Effector memory differentiation increases detection of replication-competent HIV-l in resting CD4+ T cells from virally suppressed individuals.

Wonderlich E, Subramanian K, Cox B, Wiegand A, Lackman-Smith C, Bale M PLoS Pathog. 2019; 15(10):e1008074.

PMID: 31609991 PMC: 6812841. DOI: 10.1371/journal.ppat.1008074.

References

Ibanez A, Puig T, Elias J, Clotet B, Ruiz L, Martinez M . Quantification of integrated and total HIV-1 DNA after long-term highly active antiretroviral therapy in HIV-1-infected patients. AIDS. 1999; 13(9):1045-9. DOI: 10.1097/00002030-199906180-00007. View

Wiskerchen M, Muesing M . Identification and characterization of a temperature-sensitive mutant of human immunodeficiency virus type 1 by alanine scanning mutagenesis of the integrase gene. J Virol. 1995; 69(1):597-601. PMC: 188617. DOI: 10.1128/JVI.69.1.597-601.1995. View

Tobin N, Learn G, Holte S, Wang Y, Melvin A, McKernan J . Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus. J Virol. 2005; 79(15):9625-34. PMC: 1181593. DOI: 10.1128/JVI.79.15.9625-9634.2005. View

Jelinek W, Schmid C . Repetitive sequences in eukaryotic DNA and their expression. Annu Rev Biochem. 1982; 51:813-44. DOI: 10.1146/annurev.bi.51.070182.004121. View

Butler S, Johnson E, Bushman F . Human immunodeficiency virus cDNA metabolism: notable stability of two-long terminal repeat circles. J Virol. 2002; 76(8):3739-47. PMC: 136088. DOI: 10.1128/jvi.76.8.3739-3747.2002. View

Chomont N, El-Far M, Ancuta P, Trautmann L, Procopio F, Yassine-Diab B . HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med. 2009; 15(8):893-900. PMC: 2859814. DOI: 10.1038/nm.1972. View

Butler S, Hansen M, Bushman F . A quantitative assay for HIV DNA integration in vivo. Nat Med. 2001; 7(5):631-4. DOI: 10.1038/87979. View

Engelman A, Englund G, Orenstein J, Martin M, Craigie R . Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. J Virol. 1995; 69(5):2729-36. PMC: 188965. DOI: 10.1128/JVI.69.5.2729-2736.1995. View

Liszewski M, Yu J, ODoherty U . Detecting HIV-1 integration by repetitive-sampling Alu-gag PCR. Methods. 2009; 47(4):254-60. PMC: 2862469. DOI: 10.1016/j.ymeth.2009.01.002. View

10.

Archin N, Keedy K, Espeseth A, Dang H, Hazuda D, Margolis D . Expression of latent human immunodeficiency type 1 is induced by novel and selective histone deacetylase inhibitors. AIDS. 2009; 23(14):1799-806. PMC: 3809117. DOI: 10.1097/QAD.0b013e32832ec1dc. View

11.

Chun T, Engel D, Berrey M, Shea T, Corey L, Fauci A . Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection. Proc Natl Acad Sci U S A. 1998; 95(15):8869-73. PMC: 21169. DOI: 10.1073/pnas.95.15.8869. View

12.

Lu X, Humeau L, Slepushkin V, Binder G, Yu Q, Slepushkina T . Safe two-plasmid production for the first clinical lentivirus vector that achieves >99% transduction in primary cells using a one-step protocol. J Gene Med. 2004; 6(9):963-73. DOI: 10.1002/jgm.593. View

13.

Colin L, Van Lint C . Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies. Retrovirology. 2009; 6:111. PMC: 2797771. DOI: 10.1186/1742-4690-6-111. View

14.

Swiggard W, Baytop C, Yu J, Dai J, Li C, Schretzenmair R . Human immunodeficiency virus type 1 can establish latent infection in resting CD4+ T cells in the absence of activating stimuli. J Virol. 2005; 79(22):14179-88. PMC: 1280214. DOI: 10.1128/JVI.79.22.14179-14188.2005. View

15.

Bukrinsky M, Stanwick T, Dempsey M, Stevenson M . Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science. 1991; 254(5030):423-7. PMC: 9524215. DOI: 10.1126/science.1925601. View

16.

Swingler S, Mann A, Zhou J, Swingler C, Stevenson M . Apoptotic killing of HIV-1-infected macrophages is subverted by the viral envelope glycoprotein. PLoS Pathog. 2007; 3(9):1281-90. PMC: 2323301. DOI: 10.1371/journal.ppat.0030134. View

17.

Stevenson M . HIV-1 pathogenesis. Nat Med. 2003; 9(7):853-60. DOI: 10.1038/nm0703-853. View

18.

Siliciano J, Siliciano R . Enhanced culture assay for detection and quantitation of latently infected, resting CD4+ T-cells carrying replication-competent virus in HIV-1-infected individuals. Methods Mol Biol. 2005; 304:3-15. DOI: 10.1385/1-59259-907-9:003. View

19.

Ho D, ROTA T, Hirsch M . Infection of monocyte/macrophages by human T lymphotropic virus type III. J Clin Invest. 1986; 77(5):1712-5. PMC: 424579. DOI: 10.1172/JCI112491. View

20.

Nicholson J, Cross G, CALLAWAY C, McDougal J . In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). J Immunol. 1986; 137(1):323-9. View